Search
ISSUP POSTER FOR LISBON ADDICTIONS 2022: STUDY ON SUBSTANCE USE AND THE ROLE OF FAMILIES IN KAZAKHSTAN, PAKISTAN AND UKRAINE
The fourth European Conference on Addictive Behaviours and Dependencies took place in Lisbon from 23–25 November 2022.
Under the overarching theme of Global Addictions, LxAddictions22 showcased cutting-edge research to help characterise...
AddictologyIssue 1/2023
The ASPIRE Standards: Taking a Step Towards Quality Assurance in Drug Prevention in France – A Case Study
INTRODUCTION: In the favourable political climate of the mid-2010s, the standards for Assessment & Selection of Prevention programmes Issued from the Review of EDPQS (ASPIRE) were developed to support project planning in drug prevention.
...AddictologyIssue 1/2023
National Implementation of Quality Standards in Prevention and Treatment Services for Substance Use/ Addictions – A Case Study of Cyprus
INTRODUCTION: The Cyprus National Addictions Authority (NAAC) is the main coordinating body for all matters related to licit and illicit substances as well as pathological gambling in Cyprus and it is responsible, inter alia, for the...
AddictologyIssue 1/2023
Substance Use Disorder Treatment Quality Standards in Lithuania 1992–2022: From Grassroots Initiatives to Nationwide Strategies
BACKGROUND: The implementation of quality standards in the treatment of substance use disorders in Lithuania is not well documented in the literature. AIMS: To describe the process of the development of quality standards from grassroots...
AddictologyIssue 1/2023
Stress and substance use among sexual and gender minority individuals
Sexual and gender minority individuals face marked disparities in substance use.
This narrative review explores research on substance use in sexual and gender minority communities. The authors define the sexual and gender minority...
The social context of drinking among LGBT+ people
Professor Carol Emslie and David Barbour discuss research on gender, identity and drinking, and the disproportionate impact of substance use in the LGBT+ community.
Stress, Coping, and Context: Examining Substance Use Among LGBTQ Young Adults With Probable Substance Use Disorders
In this research, the authors explored how lesbian, gay, bisexual, transgender, and queer (LGBTQ) young adults with problematic substance use made sense of their substance use in relation to their LGBTQ identities.
The authors...
LGBTQ+ People and Alcohol
This briefing provides a summary of alcohol consumption, alcohol harm, alcohol treatment, and gaps in knowledge regarding alcohol use among LGBTQ+ people.
It uses the acronym LGBTQ+ to include lesbian, gay, bisexual, transgender, queer...
Substance Use in the LGBTQ+ Community: Reading List
Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ+) Pride month is celebrated each year during the month of June. Here you can find a list of resources and research on the topic of substance use among the LGBTQ+ community.
1) This rep...
European Drug Report 2023: Trends and Developments
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national...
Treatment and Prevention of Substance Use Disorders in the Workplace
ISSUP Kenya present their webinar on Workplace Substance Use.
Efectos del uso de cannabis fumada en adolescentes escolares
ISSUP Chile presentó un Webinar sobre 'Efectos del uso de cannabis fumada en adolescentes escolares'.
Reducing stigma towards people living with HIV and people who inject drugs
Despite extensive evidence regarding the negative effects of stigma experienced by people living with HIV (PLHIV) and people who inject drugs within health care settings, comparatively little evidence exists regarding the effectiveness of...
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Abstract
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Strategies to Address Cocaine and Methamphetamine
Presented by Richard Rawson, PhD, Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont, this presentation provided an overview of the...
72º Regular Session of the Inter-American Drug Abuse Control Comission was held
In the magazine CIJ Informa, the participation of CIJ, host chapter institution of ISSUP Mexico, in the 71st Regular Session of CICAD is reviewed.
The Anti-Stigma Network
The Anti-Stigma Network has been launched!
The Mission
The Anti-Stigma Network has been created by a group of organisations coming together with a shared mission.
Collectively they aim to improve understanding of the stigma and...
Buprenorphine versus methadone for the treatment of opioid dependence
Summary
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...